AzTrials
AzTrials

Arthroscopic Knee Ligament ReconstructionPhase 4NCT02951520

A Novel Single-puncture Triple Nerve Block; Sciatic, Obturator, Femoral Technique (SOFT), as a Sole Anesthesia for Knee Surgeries

A Phase 4 study testing new technique for lower limb nerve blocks using a single skin puncture (SOFT block) in people with Arthroscopic Knee Ligament Reconstruction, run by Healthpoint Hospital at 1 site in United Arab Emirates.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to describe and to evaluate the effectiveness (success rate) of a supine ultrasound (US) guided single-puncture sciatic, obturator and femoral neve block technique (SOFT block) in knee surgery. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
new technique for lower limb nerve blocks using a single skin puncture (SOFT block)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited Arab Emirates
Study dates
Oct 2016to Apr 2017
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients scheduled for arthroscopic knee ligament reconstruction

Who cannot join

  • BMI > 30 kg.m-2,
  • ASA physical state >II
  • Allergy to the used local anesthetics
  • Infection at the injection site
  • age <18y

Trial locations and contacts

1 site in 1 country.

Ahmad M Taha, MD contact

00971508297326

ahmadtaha_1@yahoo.com

United Arab Emirates1 site, 1 recruiting
  • Healthpoint Hospital

    Abu Dhabi, Abu Dhabi Emirate, 112308

    Sabah Zahooruddin, +971 2 4921304, s.zahooruddin@healthpoint.ae

    Recruiting

Other trials in United Arab Emirates

About this study

This study aims to describe and to evaluate the effectiveness (success rate) of a supine ultrasound (US) guided single-puncture sciatic, obturator and femoral neve block technique (SOFT block) in knee surgery.

Read the detailed description

Under aseptic technique, all the patients will receive US-guided femoral, obturator and sciatic nerve blocks using a single puncture point. All blocks will be performed by an expert anesthetist. The femoral nerve will be blocked lateral to the femoral artery. The obturator nerve will be blocked after it exits the obturator canal (deep to pectineus muscle). While the sciatic nerve will be blocked deep (posterior) to the inferior border of quadratus femoris muscle. The motor block of the femoral, obturator and sciatic nerves and sensory block of the lateral femoral cutaneous nerve (LFCN) will be assessed before shifting the patient to the operating room.

The performance time, patient discomfort, technique success rate, the associated successful LFCN block and any complication will be recorded by the assistant. All patients were assessed neurologically before discharge and during the physiotherapy visits for 3 weak after surgery.

Being tested
new technique for lower limb nerve blocks using a single skin puncture (SOFT block)
Keywords
Patients

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • new technique for lower limb nerve blocks using a single skin puncture (SOFT block)Procedure or surgery

    The patients will be in supine position. The block needle will be inserted at the inguinal crease (medial to the femoral vein) and advanced towards the femoral nerve, then redirected towards the obturator nerve (deep to the pectineus muscle). Lastly, it will be redirected posteriorly towards the sciatic nerve (deep to the quadratus femoris muscle). A ropivacaine-lidocaine-epinephrine mixture will be used to block these nerves. The block success rate (painless surgery), performance time and patient discomfort will be recorded.

Study groups in NCT02951520
Study groupRoleWhat they receive
SOFT blockExperimentalFifty patients will form the study group (one group). All the patients will receive supine ultrasound guided (US) sciatic, obturator, femoral nerve block technique using a single skin puncture (SOFT block).
Receives: Procedure: new technique for lower limb nerve blocks using a single skin puncture (SOFT block)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. success rate

    Measured: within the perioperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2016 (estimated)
  2. Study startOct 2016
  3. Primary completionApr 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02951520
Sponsor's protocol ID
REC 001
Status last verified
Nov 2016
First submitted
29 Oct 2016
Last updated
3 Nov 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing new technique for lower limb nerve blocks using a single skin puncture (SOFT block) in people with Arthroscopic Knee Ligament Reconstruction, run by Healthpoint Hospital at 1 site in United Arab Emirates.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Arab Emirates. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmad M Taha, MD (00971508297326, ahmadtaha_1@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

success rate (time frame: within the perioperative period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in